News and Trends 30 Nov 2022
bit.bio expands portfolio for drug discovery in neurodegenerative and neurological diseases
Cell coding company bit.bio has made three additions to its product portfolio: ioGlutamatergic Neurons MAPT N279K and ioGlutamatergic Neurons MAPT…